Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

A venous thromboembolism (VTE) with the subsequent risk of pulmonary embolism is a major concern in the treatment of patients with multiple myeloma with thalidomide. The susceptibility to developing a VTE in response to thalidomide therapy is likely to be influenced by both genetic and environmental...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Johnson, David C., Corthals, Sophie, Ramos, Christine, Hoering, Antje, Cocks, Kim, Dickens, Nicholas J., Haessler, Jeff, Goldschmidt, Harmut, Child, J. Anthony, Bell, Sue E., Jackson, Graham, Baris, Dalsu, Rajkumar, S. Vincent, Davies, Faith E., Durie, Brian G. M., Crowley, John, Sonneveld, Pieter, Van Ness, Brian, Morgan, Gareth J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2008
Matèries:
Hemostasis, Thrombosis, and Vascular Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3601865/
https://ncbi.nlm.nih.gov/pubmed/18805967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140434
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars